News on Allergy from BioPortfolio.com http://www.BioPortfolio.com Consolidated Allergy news from BioPortfolio.com Tue, 09 Feb 2010 23:16:48 GMT en Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037140&HITNO=0&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037140&THISHREF=http://c.moreover.com/click/here.pl%3fz2536919873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037140&HITNO=0&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037140&THISHREF=http://c.moreover.com/click/here.pl%3fz2536919873%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037009&HITNO=1&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037009&THISHREF=http://c.moreover.com/click/here.pl%3fz2536859850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037009&HITNO=1&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037009&THISHREF=http://c.moreover.com/click/here.pl%3fz2536859850%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036991&HITNO=2&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036991&THISHREF=http://c.moreover.com/click/here.pl%3fz2536858287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036991&HITNO=2&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036991&THISHREF=http://c.moreover.com/click/here.pl%3fz2536858287%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Reportlinker Adds What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036988&HITNO=3&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036988&THISHREF=http://c.moreover.com/click/here.pl%3fz2536856680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036988&HITNO=3&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036988&THISHREF=http://c.moreover.com/click/here.pl%3fz2536856680%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: Herbals Not the Answer for Asthma, Study Showshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036145&HITNO=4&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036145&THISHREF=http://c.moreover.com/click/here.pl%3fz2536508654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036145&HITNO=4&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036145&THISHREF=http://c.moreover.com/click/here.pl%3fz2536508654%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedicineNet.com: GeoVax Labs, Inc. Begins Enrollment At Final Site For Preventative Vaccine; Next Step Is To Submit IND Application For Therapeutic Vaccine To FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036061&HITNO=5&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036061&THISHREF=http://c.moreover.com/click/here.pl%3fz2536484788%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036061&HITNO=5&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036061&THISHREF=http://c.moreover.com/click/here.pl%3fz2536484788%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipelinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035211&HITNO=6&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035211&THISHREF=http://c.moreover.com/click/here.pl%3fz2536158644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035211&HITNO=6&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035211&THISHREF=http://c.moreover.com/click/here.pl%3fz2536158644%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYour Story: GeoVax Labs provides update on vaccine trials progresshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034625&HITNO=7&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034625&THISHREF=http://c.moreover.com/click/here.pl%3fz2535894643%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034625&HITNO=7&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034625&THISHREF=http://c.moreover.com/click/here.pl%3fz2535894643%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Paxil blocks effect of breast cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034253&HITNO=8&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034253&THISHREF=http://c.moreover.com/click/here.pl%3fz2535689856%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034253&HITNO=8&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034253&THISHREF=http://c.moreover.com/click/here.pl%3fz2535689856%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comToronto Star Online: Early exposure to solid foods and the development of eczema in children up to 4 years of agehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034165&HITNO=9&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034165&THISHREF=http://c.moreover.com/click/here.pl%3fz2535671938%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034165&HITNO=9&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034165&THISHREF=http://c.moreover.com/click/here.pl%3fz2535671938%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032550&HITNO=10&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032550&THISHREF=http://c.moreover.com/click/here.pl%3fz2534701587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032550&HITNO=10&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032550&THISHREF=http://c.moreover.com/click/here.pl%3fz2534701587%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: GeoVax Labs, Inc. Begins Enrollment at Final Site for Preventative Vaccine; Next Step Is to Submit IND Application for Therapeutic Vaccine to FDAhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031900&HITNO=11&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031900&THISHREF=http://c.moreover.com/click/here.pl%3fz2534421318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031900&HITNO=11&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031900&THISHREF=http://c.moreover.com/click/here.pl%3fz2534421318%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comcompaniesandmarkets.com: Phadia Brings the First and Only Point of Care in Vitro Specific IgE Allergy Test Into the Physician's Officehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031757&HITNO=12&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031757&THISHREF=http://c.moreover.com/click/here.pl%3fz2534358340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031757&HITNO=12&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031757&THISHREF=http://c.moreover.com/click/here.pl%3fz2534358340%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Phadia Brings the First and Only Point of Care in Vitro Specific IgE Allergy Test Into the Physician's Office With Final FDA Clehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030733&HITNO=13&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030733&THISHREF=http://c.moreover.com/click/here.pl%3fz2533798738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030733&HITNO=13&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030733&THISHREF=http://c.moreover.com/click/here.pl%3fz2533798738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEuroInvestor.co.uk: Phadia Brings the First and Only Point of Care in Vitro Specific IgE Allergy Test Into the Physician's Office With Final FDA Clearance of the ImmunoCAP(R) Rapid Systemhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030025&HITNO=14&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030025&THISHREF=http://c.moreover.com/click/here.pl%3fz2533390206%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4030025&HITNO=14&MSIZE=291&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Allergy&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4030025&THISHREF=http://c.moreover.com/click/here.pl%3fz2533390206%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: